Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Anti-Thyroid Drugs Market In 2029?

The market for anti-thyroid drugs has experienced steady growth in the past few years. It is expected to increase from $2.44 billion in 2024 to a value of $2.5 billion in 2025, representing a compound annual growth rate (CAGR) of 2.2%. This growth during the historical period can be traced back to the increasing occurence of thyroid disorders, developments in drug creation and enhancements in healthcare infrastructure.

What Growth Rate Is Forecasted for the Anti-Thyroid Drugs Market by 2029?

Expectations are set for the anti-thyroid drugs market size to experience consistent growth over the next few years. The market is predicted to hit the $2.78 billion mark by 2029, boasting a compound annual growth rate (CAGR) of 2.7%. This anticipated growth in the forecast period can be credited to factors such as patient education and awareness, healthcare expenditure, patient demographics, and the world’s economic conditions. Major advancements projected during this period encompass alternatives to thyroid surgery and radioactive iodine, patient-oriented care, and the rise of telemedicine and remote monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which Key Companies Are Shaping the Future of the Anti-Thyroid Drugs Market?

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

Which Factors Are Driving Demand in the Anti-Thyroid Drugs Industry?

Hyperthyroidism, in numerous instances, is directly associated with Graves’ disease, which is showing a growing prevalence trend. As per the National Library of Medicine, a biomedical library run by the US federal government, Graves’ disease (GD) is the primary cause of hyperthyroidism in developed nations. This disease is predominantly experienced in the age group of 30 to 60, with women proving to be 5–10 times more susceptible than men. The risk of developing GD can largely be attributed to genetic factors, with a 79% likelihood, while environmental elements contribute around 21% to the risk. The tremendous increase in the occurrence of Graves’ disease has led to a rise in hyperthyroidism cases. This leads to a boost in demand for anti-thyroid medications, thereby aiding the market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

How Is the Anti-Thyroid Drugs Market Segmented by Several Divisions?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

What are the Emerging Market Trends Driving the Growth of the Anti-Thyroid Drugs Industry?

Organizations dedicated to thyroid care are initiating measures to expand awareness of thyroid disorders, recent treatment advancements, and various thyroid disorder research findings. In the United States, around 60% of those with hyperthyroidism are unaware of their condition and remain without a diagnosis. The American Thyroid Association (ATA) and other associations are addressing these concerns by raising awareness about thyroid disorders. The Thyroid Foundation of Canada is also taking steps to increase public knowledge and understanding of thyroid diseases, including hyperthyroidism. Among others initiating awareness initiatives and programs are the American Academy of Otolaryngology and the British Thyroid Foundation.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Which Regions Are Driving Growth in the Anti-Thyroid Drugs Market?

North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

This Report Delivers Insight On:

1. How big is the anti-thyroid drugs market, and how is it changing globally?

2. Who are the major companies in the anti-thyroid drugs market, and how are they performing?

3. What are the key opportunities and risks in the anti-thyroid drugs market right now?

4. Which products or customer segments are growing the most in the anti-thyroid drugs market?

5. What factors are helping or slowing down the growth of the anti-thyroid drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model